279 related articles for article (PubMed ID: 31646432)
21. [The Costs of Overweight and Obesity: a Systematic Review].
Konnopka A; Dobroschke A; Lehnert T; König HH
Gesundheitswesen; 2018 May; 80(5):471-481. PubMed ID: 28561182
[TBL] [Abstract][Full Text] [Related]
22. Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimates.
Baral R; Nonvignon J; Debellut F; Agyemang SA; Clark A; Pecenka C
BMC Public Health; 2020 May; 20(1):619. PubMed ID: 32370763
[TBL] [Abstract][Full Text] [Related]
23. Short-term persistence of high health care costs in a nationally representative sample of children.
Liptak GS; Shone LP; Auinger P; Dick AW; Ryan SA; Szilagyi PG
Pediatrics; 2006 Oct; 118(4):e1001-9. PubMed ID: 17015496
[TBL] [Abstract][Full Text] [Related]
24. Comparative cost analysis of generalized anxiety disorder and major depressive disorder patients in secondary care from a national hospital registry in Finland.
Kujanpää T; Ylisaukko-Oja T; Jokelainen J; Linna M; Timonen M
Nord J Psychiatry; 2014 Jul; 68(5):306-10. PubMed ID: 23931684
[TBL] [Abstract][Full Text] [Related]
25. The costs associated with antidepressant use in depression and anxiety in community-living older adults.
Vasiliadis HM; Latimer E; Dionne PA; Préville M
Can J Psychiatry; 2013 Apr; 58(4):201-9. PubMed ID: 23547643
[TBL] [Abstract][Full Text] [Related]
26. The cost-effectiveness of short-term psychodynamic psychotherapy and solution-focused therapy in the treatment of depressive and anxiety disorders during a one-year follow-up.
Maljanen T; Paltta P; Harkanen T; Virtala E; Lindfors O; Laaksonen MA; Knekt P;
J Ment Health Policy Econ; 2012 Mar; 15(1):13-23. PubMed ID: 22611089
[TBL] [Abstract][Full Text] [Related]
27. Methodological considerations in the assessment of direct and indirect costs of back pain: A systematic scoping review.
Zemedikun DT; Kigozi J; Wynne-Jones G; Guariglia A; Roberts T
PLoS One; 2021; 16(5):e0251406. PubMed ID: 33974661
[TBL] [Abstract][Full Text] [Related]
28. Economic evaluation of seizures associated with solitary cysticercus granuloma.
Murthy JM; Rajshekar G
Neurol India; 2007; 55(1):42-5. PubMed ID: 17272898
[TBL] [Abstract][Full Text] [Related]
29. [The cost of schizophrenia: a literature review].
Charrier N; Chevreul K; Durand-Zaleski I
Encephale; 2013 May; 39 Suppl 1():S49-56. PubMed ID: 23351935
[TBL] [Abstract][Full Text] [Related]
30. Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders.
Issakidis C; Sanderson K; Corry J; Andrews G; Lapsley H
Psychol Med; 2004 Jan; 34(1):19-35. PubMed ID: 14971624
[TBL] [Abstract][Full Text] [Related]
31. The economic burden of anxiety disorders in the 1990s.
Greenberg PE; Sisitsky T; Kessler RC; Finkelstein SN; Berndt ER; Davidson JR; Ballenger JC; Fyer AJ
J Clin Psychiatry; 1999 Jul; 60(7):427-35. PubMed ID: 10453795
[TBL] [Abstract][Full Text] [Related]
32. Transferability of indirect cost of chronic disease: a systematic review and meta-analysis.
Zhao FL; Xie F; Hu H; Li SC
Pharmacoeconomics; 2013 Jun; 31(6):501-8. PubMed ID: 23620212
[TBL] [Abstract][Full Text] [Related]
33. Cost of epilepsy: a systematic review.
Strzelczyk A; Reese JP; Dodel R; Hamer HM
Pharmacoeconomics; 2008; 26(6):463-76. PubMed ID: 18489198
[TBL] [Abstract][Full Text] [Related]
34. Cost of Illness of Multiple Sclerosis - A Systematic Review.
Ernstsson O; Gyllensten H; Alexanderson K; Tinghög P; Friberg E; Norlund A
PLoS One; 2016; 11(7):e0159129. PubMed ID: 27411042
[TBL] [Abstract][Full Text] [Related]
35. Variation in out of pocket health care costs for individuals with anxiety disorders by type of insurance coverage.
Tucker K; Dark T; Harman JS
J Anxiety Disord; 2018 Aug; 58():18-22. PubMed ID: 29935451
[TBL] [Abstract][Full Text] [Related]
36. Direct, indirect and intangible costs of acute hand and wrist injuries: A systematic review.
Robinson LS; Sarkies M; Brown T; O'Brien L
Injury; 2016 Dec; 47(12):2614-2626. PubMed ID: 27751502
[TBL] [Abstract][Full Text] [Related]
37. The economic burden of systemic sclerosis-A systematic review.
Chen Y; Wu L; J Hernández-Muñoz J; J Miller M; Pope M; Huyan Y; Zhong L
Int J Rheum Dis; 2022 Feb; 25(2):110-120. PubMed ID: 34970861
[TBL] [Abstract][Full Text] [Related]
38. Humanistic and economic burden of generalized anxiety disorder in North America and Europe.
Revicki DA; Travers K; Wyrwich KW; Svedsäter H; Locklear J; Mattera MS; Sheehan DV; Montgomery S
J Affect Disord; 2012 Oct; 140(2):103-12. PubMed ID: 22154706
[TBL] [Abstract][Full Text] [Related]
39. Indirect costs of diabetes and its impact on the public finance: the case of Poland.
Torój A; Mela A
Expert Rev Pharmacoecon Outcomes Res; 2018 Feb; 18(1):93-105. PubMed ID: 28796563
[TBL] [Abstract][Full Text] [Related]
40. Cost of lung cancer: a methodological review.
Molinier L; Combescure C; Chouaïd C; Daurès JP; Housset B; Fabre D; Grand A; Vergnenègre A
Pharmacoeconomics; 2006; 24(7):651-9. PubMed ID: 16802841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
